Systematic review of outcome domains and instruments used in clinical trials of tinnitus treatments in adults

Trials

Volumn 17, Issue 1, 2016, Pages

  Hall, Deborah A ^a,b   Haider, Haula ^c   Szczepek, Agnieszka J ^d   Lau, Pia ^e   Rabau, Sarah ^f   Jones Diette, Julie ^a,g   Londero, Alain ^h   Edvall, Niklas K ⁱ   Cederroth, Christopher R ⁱ   Mielczarek, Marzena ^j   Fuller, Thomas ^k,l   Batuecas Caletrio, Angel ^m   Brueggemen, Petra ^d   Thompson, Dean M ^a,b   Norena, Arnaud ⁿ   Cima, Rilana F F ^k,l   Mehta, Rajnikant L ^a,b   Mazurek, Birgit ^d  

^a National Institute for Health Research ^*  (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NOVA MEDICAL SCHOOL   (Portugal)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^f ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^g UNIVERSITY OF YORK   (United Kingdom)

^h HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

ⁱ KAROLINSKA INSTITUTE   (Sweden)

^j MEDICAL UNIVERSITY OF LODZ   (Poland)

^k MAASTRICHT UNIVERSITY   (Netherlands)

^l ADELANTE   (Netherlands)

^m HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

ⁿ AIX MARSEILLE UNIVERSITÉ   (France)

more..

Author keywords

Adult otolaryngology; Audiology; Clinical trials; Methods

Indexed keywords

ADULT; ANXIETY; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; COMORBIDITY; CONTROLLED CLINICAL TRIAL (TOPIC); DEPRESSION; DISEASE ASSESSMENT; DISEASE SEVERITY; DISTRESS SYNDROME; HEALTH IMPACT ASSESSMENT; HEARING; HEARING IMPAIRMENT; HEARING TEST; HUMAN; INTERVENTION STUDY; LOUDNESS; LOUDNESS DISCOMFORT LEVEL; LOUDNESS MATCHING; MINIMUM MASKING LEVEL; NUMERICAL RATING SCALE; OUTCOME ASSESSMENT; QUALITY CONTROL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; STUDY DESIGN; SYSTEMATIC REVIEW; TINNITUS; TINNITUS HANDICAP INVENTORY; METHODOLOGY; TREATMENT OUTCOME;

ADULT; CLINICAL TRIALS AS TOPIC; HUMANS; RESEARCH DESIGN; TINNITUS; TREATMENT OUTCOME;

EID: 84971554690     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/s13063-016-1399-9     Document Type: Article

References (45)

1. Davis A, Refaie AE. Chapter 1: Epidemiology of tinnitus. In: Tyler RS, editor. Tinnitus Handbook. San Diego: Singular Publishing Group; 2000. p. 1-24.
2. Langguth B, Kreuzer PM, Kleinjung T, De Ridder D. Tinnitus: causes and clinical management. Lancet Neurol. 2013;12(9):920-30. doi: 10.1016/s1474-4422(13)70160-1.
3. Schaette R. Tinnitus in men, mice (as well as other rodents), and machines. Hear Res. 2014;311:63-71. doi: http://dx.doi.org/ 10.1016/j.heares.2013.12.004. Epub 25 Dec 2013.
4. Landgrebe M, Zeman F, Koller M, Eberl Y, Mohr M, Reiter J, et al. The Tinnitus Research Initiative (TRI) database: a new approach for delineation of tinnitus subtypes and generation of predictors for treatment outcome. BMC Med Inform Decis Mak. 2010;10(1):42. doi: 10.1186/1472-6947-10-42. PubMed PMID: 20682024, PubMed Central PMCID: PMC2920857.
5. Tyler RS, Baker LJ. Difficulties experienced by tinnitus sufferers. J Speech Hear Disord. 1983;48(2):150-4.
6. Hoare DJ, Kowalkowski VL, Kang S, Hall DA. Systematic review and meta analyses of randomized controlled trials examining tinnitus management. Laryngoscope. 2011;121(7):1555-64. doi: 10.1002/lary.21825. PubMed PMID: 21671234, PubMed Central PMCID: PMC3477633, Epub 10 Jun 2011. Review.
7. Martinez-Devesa P, Perera R, Theodoulou M, Waddell A. Cognitive behavioural therapy for tinnitus. Cochrane Database Syst Rev. 2010;1:9. doi: 10.1002/14651858.CD005233.pub3.
8. Cima RF, Maes IH, Joore MA, Scheyen DJ, El Refaie A, Baguley DM, et al. Specialised treatment based on cognitive behaviour therapy versus usual care for tinnitus: a randomised controlled trial. Lancet. 2012;379(9830):1951-9. doi: 10.1016/s0140-6736(12)60469-3.
9. Langguth B. Tinnitus: the end of therapeutic nihilism. Lancet. 2012;379(9830):1926-8. doi: 10.1016/S0140-6736(12)60561-3.
10. Hall DA, Haider H, Kikidis D, Mielczarek M, Mazurek B, Szczepek AJ, et al. Toward a global consensus on outcome measures for clinical trials in tinnitus: report from the First International Meeting of the COMiT Initiative, 14 November 2014, Amsterdam, The Netherlands. Trends in Hearing. 2015;19. doi: 10.1177/2331216515580272. PubMed PMID: 25910505; PubMed Central PMCID: PMC4409939
11. Plein CT, Harounian J, Floyd E, Irizarry R, Ferzli G, Kidwai S, et al. A systematic review of eligibility and outcomes in tinnitus trials. Reassessment of tinnitus guideline. Otolaryngol Head Neck Surg. 2016;154(1):24-32. doi: 10.1177/0194599815608160. Epub 12 Oct 2015. Review.
12. Tunkel DE, Bauer CA, Sun GH, Rosenfeld RM, Chandrasekhar SS, Cunningham ER, et al. Clinical practice guideline tinnitus. Otolaryngol Head Neck Surg. 2014;151(2 Suppl):S1-40. doi: 10.1177/0194599814545325.
13. Hall DA, Láinez MJ, Newman CW, Sanchez TG, Egler M, Tennigkeit F, et al. Treatment options for subjective tinnitus: self reports from a sample of general practitioners and ENT physicians within Europe and the USA. BMC Health Serv Res. 2011;11(1):302. doi: 10.1186/1472-6963-11-302. PubMed PMID: 22053947, PubMed Central PMCID: PMC3227628.
14. Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, et al. Developing core outcome sets for clinical trials: issues to consider. Trials. 2012;13(132):1-8. doi: 10.1186/1745-6215-13-132. PubMed PMID: 22867278, PubMed Central PMCID: PMC3472231.
15. Langguth B, Goodey R, Azevedo A, Bjorne A, Cacace A, Crocetti A, et al. Consensus for tinnitus patient assessment and treatment outcome measurement: Tinnitus Research Initiative meeting, Regensburg, July 2006. Prog Brain Res. 2007;166:525-36. doi: 10.1016/s0079-6123(07)66050-6. PubMed PMID: 17956816, PubMed Central PMCID: PMC4283806.
16. Hall DA, Szczepek AJ, Kennedy V, Haider H. Current-reported outcome domains in studies of adults with a focus on the treatment of tinnitus: protocol for a systematic review. BMJ Open. 2015;5(11), e009091. doi: 10.1136/bmjopen-2015-009091. PubMed PMID: 26560061, PubMed Central PMCID: PMC4654381.
17. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151(4):W65. doi: 10.1016/j.jclinepi.2009.06.006. PubMed Central PMCID: PMC2714672, Epub 23 Jul 2009.
18. Needleman I, Chin S, O'Brien T, Petrie A, Donos N. Systematic review of outcome measurements and reference group(s) to evaluate and compare implant success and failure. J Clin Periodontol. 2012;39(s12):122-32. doi: 10.1111/j.1600-051X.2011.01836.x.
19. Hutton JL, Williamson PR. Bias in meta-analysis due to outcome variable selection within studies. Appl Stat. 2000;49:359-70.
20. Dwan K, Gamble C, Kolamunnage-Dona R, Mohammed S, Powell C, Williamson PR. Assessing the potential for outcome reporting bias in a review: a tutorial. Trials. 2010;11(1):52. doi: 10.1186/1745-6215-11-52. PubMed PMID: 20462436, PubMed Central PMCID: PMC2888817.
21. Smyth RM, Kirkham JJ, Jacoby A, Altman DG, Gamble C, Williamson PR. Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists. BMJ. 2011;342:c7153. doi: 10.1136/bmj.c7153. PubMed PMID: 21212122, PubMed Central PMCID: PMC3016816.
22. Effective Practice and Organisation of Care (EPOC). What outcomes should be reported in EPOC reviews? EPOC Resources for review authors. Oslo: Norwegian Knowledge Centre for the Health Services; 2013. http://epoc.cochrane.org/sites/epoc.cochrane.org/files/uploads/06%20What%20outcomes%20should%20be%20reported%20in%20EPOC%20reviews%202013%2008%2012_1.pdf. Accessed 29 May 2016.
23. Newman CW, Jacobson GP, Spitzer JB. Development of the tinnitus handicap inventory. Arch Otolaryngol Head Neck Surg. 1996;122(2):143-8.
24. Goebel G, Hiller W. The tinnitus questionnaire. A standard instrument for grading the degree of tinnitus. Results of a multicenter study with the tinnitus questionnaire. HNO. 1994;42(3):166-72. German.
25. Hallam RS, Jakes SC, Hinchcliffe R. Cognitive variables in tinnitus annoyance. Br J Clin Psychol. 1988;27(3):213-22.
26. World Health Organisation. www.who.int/healthinfo/global_burden_disease/definition_regions/en/. Accessed 29 May 2016.
27. Pulte I. Efficacy, safety and tolerability of neramexane in comparison to placebo in patients with subjective tinnitus. ClinicalTrials.gov Identifier: NCT00772980. 2008.
28. Fackrell K, Hall DA, Barry J, Hoare DJ. Tools for tinnitus measurement: development and validity of questionnaires to assess handicap and treatment effects. In: Signorelli F, Turjman F, editors. Tinnitus: causes, treatment and short and long-term health effects. New York: Nova Science Publishers Inc; 2014. p. 13-60.
29. Newman CW, Sandridge SA, Jacobson GP. Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome. J Am Acad Audiol. 1998;9(2):153-60.
30. US Food and Drink Administration, Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009. Silver Spring. http://www.fda.gov/downloads/Drugs/.../Guidances/UCM193282.pdf. Accessed 29 May 2016.
31. Robinson SK, Viirre ES, Bailey KA, Kindermann S, Minassian AL, Goldin PR, et al. A randomized controlled trial of cognitive-behavior therapy for tinnitus. Int Tinnitus J. 2008;14(2):119-26.
32. Mazurek B, Haupt H, Szczepek AJ, Sandmann J, Gross J, Klapp BF, et al. Evaluation of vardenafil for the treatment of subjective tinnitus: a controlled pilot study. J Negat Results Biomed. 2009;8(1):3. doi: 10.1186/1477-5751-8-3. PubMed PMID: 19222841, PubMed Central PMCID: PMC2649886.
33. Olze H, Szczepek AJ, Haupt H, Zirke N, Graebel S, Mazurek B. The impact of cochlear implantation on tinnitus, stress and quality of life in postlingually deafened patients. Audiol Neurootol. 2012;17(1):2-11. doi: 10.1159/000323847. Epub 29 Apr 2011.
34. Nakamaru Y. Open-label crossover study for the efficacy of escitalopram and mecobalamin for patients with tinnitus. UMIN Clinical Trials Registry (UMIN-CTR) 2014. UMIN000013421.
35. Hoare DJ, Edmondson-Jones M, Sereda M, Akeroyd MA, Hall D. Amplification with hearing aids for patients with tinnitus and co-existing hearing loss. Cochrane Database of Systematic Reviews 2014, Issue 1. Art. No.: CD010151. doi: 10.1002/14651858.CD010151.pub2
36. Hobson J, Chisholm E, El Refaie A. Sound therapy (masking) in the management of tinnitus in adults. Cochrane Database of Systematic Reviews 2012, Issue 11. Art. No.: CD006371. doi: 10.1002/14651858.CD006371.pub3.
37. Epstein J, Santo RM, Guillemin F. A review of guidelines for cross-cultural adaptation of questionnaires could not bring out a consensus. J Clin Epidemiol. 2015;68(4):435-41. doi: 10.1016/j.jclinepi.2014.11.021.
38. Kuk FK, Tyler RS, Russell D, Jordan H. The psychometric properties of a tinnitus handicap questionnaire. Ear Hear. 1990;11(6):434-45.
39. Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med. 2004;141(10):781-8.
40. Granberg S, Dahlström J, Möller C, Kähäri K, The DB. ICF. Core Sets for hearing loss-researcher perspective. Part I: Systematic review of outcome measures identified in audiological research. Int J Audiol. 2014;53(2):65-76. doi: 10.3109/14992027.2013.851799.
41. Barker F, MacKenzie E, Elliott L, de Lusignan S. Outcome measurement in adult auditory rehabilitation: a scoping review of measures used in randomized controlled trials. Ear Hear. 2015;36:567-73. doi: 10.1097/AUD.0000000000000167.
42. Maund E, Tendal B, Hróbjartsson A, Jørgensen KJ, Lundh A, Schroll J, et al. Benefits and harms in clinical trials of duloxetine for treatment of major depressive disorder: comparison of clinical study reports, trial registries, and publications. BMJ. 2014;4:348. doi: 10.1136/bmj.g3510. PubMed PMID: 24899650, PubMed Central PMCID: PMC4045316.
43. Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M, et al. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012;28(2):138-44. doi: 10.1017/S0266462312000086.
44. Macefield RC, Jacobs M, Korfage IJ, Nicklin J, Whistance RN, Brookes ST, et al. Developing core outcomes sets: methods for identifying and including patient-reported outcomes (PROs). Trials. 2014;15(1):49. doi: 10.1186/1745-6215-15-49. PubMed PMID: 24495582, PubMed Central PMCID: PMC3916696.
45. Moher D, Hopewell S, Schulz KF, Montoni V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.